Abstract

In this work, we develop recombinant human cationic ferritin (rHCF) as a contrast agent to detect glomeruli in the kidney using positron emission tomography (PET). We first expressed recombinant human ferritin (rHF) in E. coli and then functionalized and radiolabeled it with Copper-64 (64Cu) to form 64Cu-rHCF. Intravenously injected 64Cu-rHCF bound to kidney glomeruli and was detected by PET. A subchronic toxicity study after an intravenous injection of rHCF revealed no significant toxicity. The development of rHCF is an important step toward the potential clinical translation of CF to detect the nephron number in humans.

Original languageEnglish
Pages (from-to)6392-6397
Number of pages6
JournalACS Applied Bio Materials
Volume7
Issue number10
DOIs
StatePublished - Oct 21 2024

Keywords

  • CFE-MRI
  • Glomerulus
  • Human Recombinant Ferritin
  • Kidney Nephron Number
  • Positron Emission Tomography

Fingerprint

Dive into the research topics of 'Development and Use of Human Recombinant 64Cu-rHCF as a Kidney Glomerulus-Targeted Contrast Agent for Positron Emission Tomography'. Together they form a unique fingerprint.

Cite this